ELEVATED SURFACTANT PROTEIN-A IN BRONCHOALVEOLAR LAVAGE FLUIDS FROM SARCOIDOSIS AND HYPERSENSITIVITY PNEUMONITIS PATIENTS

被引:64
作者
HAMM, H
LUHRS, J
ROTAECHE, JGY
COSTABEL, U
FABEL, H
BARTSCH, W
机构
[1] RUHR UNIV BOCHUM,DEPT PATHOL,W-4630 BOCHUM,GERMANY
[2] RUHRLANDKLIN ESSEN,DEPT PNEUMOL & ALLERGY,W-4300 ESSEN,GERMANY
[3] FRAUNHOFER INST TOXIKOL & AEROSOLFORSCH HANNOVER,DEPT CLIN CHEM,W-3000 HANNOVER,GERMANY
关键词
PULMONARY SURFACTANT; SURFACTANT PROTEIN A (SP-A); BRONCHOALVEOLAR LAVAGE (BAL); ALVEOLITIS; SARCOIDOSIS; HYPERSENSITIVITY PNEUMONITIS;
D O I
10.1378/chest.106.6.1766
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Interstitial lung diseases often are accompanied by histopathologic evidence of alveolar type 2 cell alterations. In the alveolar milieu, the surfactant-specific protein A (SP-A) is a secretory product of alveolar type 2 cells. Therefore, we measured SP-A levels in bronchoalveolar lavage (BAL) fluids from patients with untreated sarcoidosis (n=35) and hypersensitivity pneumonitis (HP [n=10]) and compared the results with those from 21 healthy control subjects. In sarcoidosis patients, SP-A was markedly higher than in control subjects with a mean of 8.0 mu g/ml of recovered BAL fluid+/-0.7 SEM (p<0.0001 compared with control subjects). In HP, SP-A values were comparable with those in sarcoidosis with a mean of 9.0 mu g/ml +/- 1.7 SEM. Mean SP-A in the control group was 4.0 mu g/ml +/- 0.3 SEM. These results suggest that SP-A secretion is stimulated in sarcoidosis and HP. Further studies seem justified to investigate the role of the surfactant system in interstitial lung diseases as well as the potential clinical usefulness of SP-A measurements in BAL.
引用
收藏
页码:1766 / 1770
页数:5
相关论文
共 33 条
[1]   SURFACTANT APOPROTEIN-A (SP-A) IS SYNTHESIZED IN AIRWAY CELLS [J].
AUTEN, RL ;
WATKINS, RH ;
SHAPIRO, DL ;
HOROWITZ, S .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 3 (05) :491-496
[2]   DECREASED PHOSPHATIDYLCHOLINE IN THE LUNG FLUID OF PATIENTS WITH SARCOIDOSIS [J].
BAUGHMAN, RP ;
STROHOFER, S ;
DOHN, M .
LIPIDS, 1985, 20 (07) :496-499
[3]  
COSTABEL U, 1985, B EUR PHYSIOPATH RES, V21, P381
[4]  
Costabel U, 1988, SARCOIDOSIS OTHER GR, P429
[5]  
FLOROS J, 1990, AM J PHYSIOL, V2, pL238
[6]   PHAGOCYTOSIS OF SURFACTANT BY ALVEOLAR MACROPHAGES INVITRO [J].
GRABNER, R ;
MEERBACH, W .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (06) :L472-L477
[7]  
GUZMAN J, 1992, ACTA CYTOL, V36, P668
[8]  
HAMM H, 1992, CLIN INVESTIGATOR, V70, P637
[9]  
Hawgood S, 1992, PULMONARY SURFACTANT, P33
[10]   CHANGES IN PHOSPHOLIPIDS IN BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH INTERSTITIAL LUNG-DISEASES [J].
HONDA, Y ;
TSUNEMATSU, K ;
SUZUKI, A ;
AKINO, T .
LUNG, 1988, 166 (05) :293-301